Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.

Arteriosclerosis, thrombosis, and vascular biology - 1 Aug 2015

Qamar Arman, Khetarpal Sumeet A, Khera Amit V, Qasim Atif, Rader Daniel J, Reilly Muredach P

Abstract excerpt

OBJECTIVE: Triglyceride-rich lipoproteins have emerged as causal risk factors for developing coronary heart disease independent of low-density lipoprotein cholesterol levels. Apolipoprotein C-III (ApoC-III) modulates triglyceride-rich lipoprotein metabolism through inhibition of lipoprotein lipase and hepatic uptake of triglyceride-rich lipoproteins. Mutations causing loss-of-function of ApoC-III lower...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein C-III
Share to Blood Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Artery Disease

Share to Diabetic Angiopathies

Share to Dyslipidemias

Share to Triglycerides

Share to Up-Regulation

Share to Vascular Calcification

Source

Open in PubMed Open full text

Identifiers

PMID: 26069232
DOI: 10.1161/ATVBAHA.115.305415
PMCID: PMC4556282

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.PMID 26069232Read ↗

Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.Semantic proximity Read ↗

APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups.Semantic proximity Read ↗

Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease.Semantic proximity Read ↗

Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.Semantic proximity Read ↗

Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.Semantic proximity Read ↗

Abdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarction.Semantic proximity Read ↗

PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid content.Semantic proximity Read ↗

A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.Semantic proximity Read ↗

[Mutations of APOC3 gene, metabolism of triglycerides and reduction of ischemic cardiovascular events].Semantic proximity Read ↗

A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.Semantic proximity Read ↗

The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides levels among diabetic subjects.Semantic proximity Read ↗

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.